Loading...
XSTONICA
Market cap15mUSD
Dec 23, Last price  
1.90SEK
1D
-1.55%
1Q
-19.15%
Jan 2017
-87.91%
IPO
-89.16%
Name

Nanologica AB (publ)

Chart & Performance

D1W1MN
XSTO:NICA chart
P/E
—
P/S
116.34
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
25.79%
Rev. gr., 5y
-19.03%
Revenues
1m
-7.20%
3,563,9174,739,2641,645,3003,262,6572,000,3872,599,8404,145,28310,226,79716,135,00012,914,0001,555,0001,443,000
Net income
-75m
L+36.43%
-5,035,778-10,064,310-14,723,760-14,290,972-22,459,617-20,095,140-20,889,107-21,473,191-24,826,000-50,132,000-55,090,000-75,157,000
CFO
-36m
L-20.72%
000-13,947,096-23,188,800-23,193,529-11,705,322-11,522,273-43,340,000-46,493,000-45,219,000-35,848,000
Earnings
May 16, 2025

Profile

Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography. Nanologica AB (publ) was founded in 2004 and is based in Södertälje, Sweden.
URL
https://www.nanologica.com/
IPO date
Oct 30, 2015
Employees
19
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,443
-7.20%
1,555
-87.96%
12,914
-19.96%
Cost of revenue
8,820
16,601
24,396
Unusual Expense (Income)
NOPBT
(7,377)
(15,046)
(11,482)
NOPBT Margin
Operating Taxes
(141)
5,303
Tax Rate
NOPAT
(7,377)
(14,905)
(16,785)
Net income
(75,157)
36.43%
(55,090)
9.89%
(50,132)
101.93%
Dividends
Dividend yield
Proceeds from repurchase of equity
100
79,803
3,435
BB yield
Debt
Debt current
530
4,026
5,099
Long-term debt
802
4,025
10,790
Deferred revenue
Other long-term liabilities
67,328
67,174
27,530
Net debt
(8,722)
(62,271)
4,188
Cash flow
Cash from operating activities
(35,848)
(45,219)
(46,493)
CAPEX
(1,756)
(8,558)
(7,249)
Cash from investing activities
(20,353)
(7,142)
(7,249)
Cash from financing activities
(4,086)
111,697
(1,639)
FCF
18,294
(10,441)
(28,088)
Balance
Cash
10,054
70,322
11,701
Long term investments
Excess cash
9,982
70,244
11,055
Stockholders' equity
(310,193)
(235,037)
(183,078)
Invested Capital
376,289
380,061
271,995
ROIC
ROCE
EV
Common stock shares outstanding
36,631
30,427
28,371
Price
Market cap
EV
EBITDA
7,102
(3,184)
(1,019)
EV/EBITDA
Interest
5,712
5,009
3,234
Interest/NOPBT